The performed trials demonstrated the very low reactogenicity of the vaccine. Only slight local reactions such as a limited induration, erythema and pain at the site of the injection may appear in some cases, possibly due to the aluminium hydroxide adjuvant. Systemic reactions such as fever, headache, nausea and weakness appeared in a few subjects, but their linkage to vaccination is doubtful and difficult to demonstrate or reject.